title: Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'.
authors.affiliation: Center of Health Informatics, Farr Institute@HeRC, Institute of Population Health, University of Manchester, Manchester, UK.
authors.forename: Ellena
authors.initials: E
authors.lastname: Badrick
authors.affiliation: Center of Health Informatics, Farr Institute@HeRC, Institute of Population Health, University of Manchester, Manchester, UK.
authors.forename: Matthew
authors.initials: M
authors.lastname: Sperrin
authors.affiliation: Center of Health Informatics, Farr Institute@HeRC, Institute of Population Health, University of Manchester, Manchester, UK.|The Christie NHS Foundation Trust, Institute of Cancer Sciences, University of Manchester, Manchester, UK.
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Renehan
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents; D010190:Pancreatic Neoplasms; D012306:Risk
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents